Metagenomic Sequencing

Metagenomic Sequencing

Global Metagenomic Sequencing Market to Reach US$9.6 Billion by 2030

The global market for Metagenomic Sequencing estimated at US$3.1 Billion in the year 2023, is expected to reach US$9.6 Billion by 2030, growing at a CAGR of 17.6% over the analysis period 2023-2030. Reagents & Consumables Component, one of the segments analyzed in the report, is expected to record a 19.3% CAGR and reach US$4.3 Billion by the end of the analysis period. Growth in the Instruments Component segment is estimated at 17.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$787.0 Million While China is Forecast to Grow at 22.8% CAGR

The Metagenomic Sequencing market in the U.S. is estimated at US$787.0 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2030 trailing a CAGR of 22.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.8% and 15.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.

Global Metagenomic Sequencing Market - Key Trends and Drivers Summarized

Why Is Metagenomic Sequencing Transforming Microbiome Research?

Metagenomic sequencing has revolutionized the field of microbiome research, providing a powerful tool for analyzing genetic material from entire microbial communities directly from environmental samples. Unlike traditional microbiological methods, which require culturing individual organisms, metagenomic sequencing enables researchers to study complex microbial ecosystems, such as the human gut, soil, or oceans, in their entirety. This technology has become essential for advancing our understanding of microbial diversity, interactions, and their roles in human health, agriculture, and environmental sustainability. As a result, metagenomic sequencing is now widely used in fields ranging from medical research to biotechnology and agriculture.

What Innovations Are Shaping the Metagenomic Sequencing Market?

Innovations in metagenomic sequencing focus on improving sequencing accuracy, reducing costs, and expanding the technology`s applications. Next-generation sequencing (NGS) platforms have significantly lowered the cost and time required for metagenomic analysis, making the technology more accessible to researchers across various industries. Additionally, the integration of machine learning algorithms is enhancing data analysis by identifying previously unknown microbial species and predicting their functions within ecosystems. Single-cell genomics and long-read sequencing are also emerging as promising innovations, allowing for more detailed and accurate analysis of microbial communities at the individual organism level.

How Do Market Segments Define the Growth of Metagenomic Sequencing?

Applications include human health and disease research, agriculture, environmental monitoring, and industrial biotechnology. Human health and disease research, particularly in areas like gut microbiome analysis and infectious disease detection, represents the largest market segment due to the growing interest in the role of microbes in human health. Technologically, next-generation sequencing dominates the market, although long-read sequencing is gaining traction for its ability to provide more comprehensive data. End-users include academic research institutions, pharmaceutical companies, and government agencies, with academic institutions leading the market due to their focus on microbial ecology and human health research.

What Factors Are Driving the Growth in the Metagenomic Sequencing Market?

The growth in the metagenomic sequencing market is driven by several factors, including the increasing focus on microbiome research, advancements in sequencing technologies, and expanding applications in healthcare and agriculture. The growing recognition of the role of the human microbiome in health and disease is fueling demand for metagenomic sequencing in medical research. Technological advancements, such as next-generation sequencing and machine learning, are improving the speed and accuracy of microbial analysis, further driving adoption. Additionally, the technology’s applications in areas like sustainable agriculture, environmental monitoring, and industrial biotechnology are expanding, contributing to market growth.

Select Competitors (Total 33 Featured) -

• BGI Group
• DNAStar, Inc.
• Eurofins Scientific
• GENEWIZ
• Illumina, Inc.
• IntegraGen SA
• Macrogen, Inc.
• Microsynth AG
• Novogene Corporation
• NuGEN Technologies, Inc.
• Oxford Nanopore Technologies Ltd.
• PerkinElmer
• QIAGEN N.V.
• Thermo Fisher Scientific, Inc.
• Zymo Research Corporation

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.